12.1 Neonatal Resuscitation, APGAR Scoring & Prematurity Complications

Physiological Transition at Birth & The Golden Minute

The transition from intrauterine fetal life to extrauterine existence requires immediate, complex cardiopulmonary adaptations within seconds of birth. In utero, the fetal lungs are fluid-filled and non-functional for gas exchange, pulmonary vascular resistance (PVR) is high, and oxygenated blood from the placenta is shunted right-to-left across the foramen ovale and ductus arteriosus. Upon delivery, clamping of the umbilical cord removes the low-resistance placental circuit, elevating systemic vascular resistance (SVR). Simultaneously, spontaneous vigorous inspirations generate negative intrathoracic pressures (-30 to -60 cmH2O), clearing alveolar fluid into pulmonary lymphatics and microvessels. Alveolar aeration with oxygen dramatically drops PVR, increasing pulmonary blood flow by eightfold, reversing ductal flow, and functionally closing the foramen ovale.

Approximately 85% of term neonates initiate spontaneous breathing without assistance, 10% respond to tactile drying and stimulation, while 4% to 5% require positive pressure ventilation (PPV), and fewer than 0.3% require chest compressions or emergency medications. Clinicians managing Caribbean deliveries must master the Golden Minute—the first 60 seconds of life in which initial assessment, thermal stabilization, airway opening, and positive pressure ventilation (if indicated) must be completed.

The Immediate Assessment Triad

Immediately upon delivery, the resuscitator asks three rapid gating questions:

1. Is the infant born at term?
2. Does the infant possess good muscle tone? (flexed extremities vs. flaccid)
3. Is the infant breathing or crying?

If all three answers are affirmative, the infant remains with the mother for immediate skin-to-skin contact, drying, covering with warm dry linen, and ongoing observation. If ANY answer is negative, the infant is immediately moved to a pre-warmed radiant warmer for resuscitation.

Initial Resuscitation Steps (0 to 30 Seconds)

1. Thermal Protection: Position infant under a radiant warmer. Preterm neonates < 32 weeks gestation should be placed directly into a food-grade polyethylene bag/wrap up to the neck without prior drying, accompanied by a warm radiant hat, to prevent catastrophic hypothermia.
2. Airway Positioning: Place the head in the neutral or slight extension "sniffing position" using a small shoulder roll (2 cm thickness) under the upper back. Hyperextension or hyperflexion obstructs the narrow, compliant neonatal pharyngeal airway.
3. Clearing Secretions: Suction secretions with a bulb syringe or wide-bore suction catheter (8F to 10F at negative pressures not exceeding 80 to 100 mmHg) ONLY when the airway appears obstructed, including during ineffective ventilation. Suction the mouth first, then the nose ("M before N") to prevent aspiration if the infant gasps during nasal stimulation. Routine vigorous suctioning of healthy or vigorous infants is strictly contraindicated because aggressive pharyngeal stimulation provokes severe vagal bradycardia, laryngospasm, and delayed onset of spontaneous breathing. If non-vigorous meconium-stained amniotic fluid is present, routine endotracheal suctioning is no longer recommended; initiate immediate resuscitation following standard NRP guidelines.
4. Drying & Tactile Stimulation: Thoroughly dry the infant's skin and discard wet towels to minimize evaporative heat loss. If spontaneous breathing is weak or absent, provide brief tactile stimulation by flicking the soles of the feet or rubbing the infant's back twice. Vigorous shaking or slapping is dangerous and strictly prohibited.

Positive Pressure Ventilation (PPV) & Corrective Actions (MR SOPA)

If after initial steps the infant remains apneic, displays gasping respirations, or exhibits a heart rate < 100 beats per minute (bpm), Positive Pressure Ventilation (PPV) must be initiated immediately—prior to 60 seconds of postnatal age.

+-----------------------------------------------------------------------------------------+
|                        POSITIVE PRESSURE VENTILATION (PPV) SETUP                        |
+-----------------------------------------------------------------------------------------+
| Indication: Apnea, gasping, or Heart Rate < 100 bpm within the Golden Minute            |
| Rate: 40 to 60 breaths per minute ("Breathe... Two... Three... Breathe...")            |
| Initial Gas: 21% O2 at>=35w;21–30% at32–34+6w;30–100% below32w; titrate to SpO2                      |
| Target Peak Inspiratory Pressure (PIP): 20 to 25 cmH2O (PEEP: 5 cmH2O)                  |
| Monitoring: Pre-ductal pulse oximeter probe placed on RIGHT wrist or hand               |
+-----------------------------------------------------------------------------------------+

Oxygen Concentration & Pre-Ductal Pulse Oximetry

Resuscitation of term and near-term infants (>= 35 weeks) must begin with room air (21% O2). For infants at32–34+6 weeks, initial 21–30% O2 is reasonable. Below32 weeks, AHA/AAP2025 permits 30–100% O2 initially. Use an air-oxygen blender and promptly titrate to preductal saturation targets, avoiding both hypoxia and hyperoxia. Initiating resuscitation with 100% O2 in term infants causes toxic reactive oxygen species (ROS) formation, cerebral vasoconstriction, myocardial reperfusion injury, and increased neonatal mortality.

A pulse oximeter probe must be attached to the right wrist or palm (pre-ductal site) to measure arterial oxygenation before right-to-left shunting across the ductus arteriosus dilutes systemic blood. The monitor is titrated against targeted normal pre-ductal SpO2 milestones:

Ventilation Rate & Pressures

Deliver breaths at a frequency of 40 to 60 breaths per minute using the cadence: "Breathe... Two... Three... Breathe...". Initial Peak Inspiratory Pressure (PIP) is set at 20 to 25 cmH2O with a Positive End-Expiratory Pressure (PEEP) of 5 cmH2O using a T-piece resuscitator or flow-inflating bag. The most critical indicator of successful PPV is a rapidly increasing heart rate.

The MR SOPA Ventilation Corrective Sequence

If the heart rate is not increasing and visible chest movement is absent within 15 seconds of initiating PPV, the clinician must execute the six sequential MR SOPA troubleshooting steps:

1. M - Mask Adjustment: Reapply the mask with a two-hand jaw-lift technique to secure an airtight perimeter seal.
2. R - Reposition Airway: Realign the head and neck into the neutral sniffing position.
   • Check: Re-attempt PPV for 5 breaths; if chest still does not move, proceed.
3. S - Suction Mouth and Nose: Clear copious secretions, meconium, or blood using a bulb syringe or 8F-10F catheter.
4. O - Open Mouth: Open the infant's mouth slightly and lift the mandible forward; insert an oral airway if micrognathia or macroglossia is present.
   • Check: Re-attempt PPV for 5 breaths; if chest still does not move, proceed.
5. P - Pressure Increase: Gradually increase PIP in increments of 5 to 10 cmH2O up to a maximum of 30 cmH2O (preterm) or 40 cmH2O (term) until bilateral chest rise is confirmed.
   • Check: If chest still fails to rise, proceed immediately to the definitive airway.
6. A - Alternative Airway: Insert an Endotracheal Tube (ETT) or a Laryngeal Mask Airway (LMA) (for infants >= 34 weeks or >= 2000 g). Confirm placement with exhaled CO2 colorimetric capnography (turning purple to yellow) and bilateral equal axillary breath sounds.

Once bilateral chest rise is achieved, provide 30 seconds of effective PPV through the definitive airway before reassessing heart rate.

Chest Compressions, Vascular Access & Emergency Pharmacotherapy

Chest compressions are indicated ONLY when the heart rate remains < 60 bpm despite at least 30 seconds of effective PPV that delivers visible chest movement (ideally through an endotracheal tube).

Chest Compression Technique

• Method: The two-thumb encircling-hands technique is universally preferred over the two-finger technique because it generates higher coronary perfusion pressures and reduces operator fatigue. Place both thumbs on the lower third of the sternum (just below the imaginary intermammary line), avoiding the xiphoid process, while fingers encircle the thorax to support the back.
• Depth: Depress the sternum by one-third of the anterior-posterior diameter of the chest, allowing full elastic chest recoil between compressions without lifting thumbs from the skin.
• Ratio & Cadence: Maintain a synchronized 3:1 compression-to-ventilation ratio (3 compressions followed by 1 breath every 2 seconds, yielding 90 compressions and 30 breaths per minute = 120 total events/min). Cadence: "One-and-two-and-three-and-breathe-and...".
• Oxygenation: Once chest compressions begin, immediately increase supplemental oxygen to 100% FiO2.
• Reassessment: Continue uninterrupted compressions for 60 seconds before pausing briefly (< 5 seconds) to reassess heart rate using a 3-lead cardiac monitor or auscultation.

Emergency Vascular Access & Umbilical Venous Catheterization (UVC)

If the heart rate remains < 60 bpm despite 60 seconds of high-quality chest compressions and 100% O2 ventilation, emergency vascular access is urgently required. Umbilical Venous Catheterization (UVC) is the rapid route of choice. Cut the umbilical cord cleanly 1 to 2 cm above the abdominal wall. Identify the single, thin-walled, wide-lumen umbilical vein (contrasting with the two smaller, thick-walled, contracted umbilical arteries located at 4 and 8 o'clock). Advance a 3.5F (preterm) or 5.0F (term) saline-flushed catheter 2 to 4 cm beneath the skin margin until free blood aspirates freely (low "emergency" position avoiding direct hepatic parenchymal infusion). Secure with a purse-string or umbilical tape. Alternatively, an intraosseous (IO) needle can be inserted into the anteromedial surface of the proximal tibia (1 to 2 cm below the tibial tuberosity).

Emergency Pharmacotherapy & Volume Expansion

1. Epinephrine (Adrenaline):
   • Indication: Heart rate persistently < 60 bpm after at least 60 seconds of coordinated compressions and effective 100% O2 ventilation.
   • Concentration: 1:10,000 (0.1 mg/mL) formulation exclusively.
   • Intravenous / Intraosseous (IV/IO) Dose: 0.01 to 0.03 mg/kg (equivalent to 0.1 to 0.3 mL/kg of 1:10,000 solution), followed immediately by a 3 mL normal saline flush to propel drug through the dead space of the catheter.
   • Endotracheal (ET) Dose: Less reliable absorption; used only as a temporary bridge while vascular access is being established. Dose is higher: 0.05 to 0.1 mg/kg (0.5 to 1.0 mL/kg of 1:10,000 solution).
   • Repeat: Administer every 3 to 5 minutes if heart rate remains < 60 bpm.
2. Volume Expansion:
   • Indication: Suspected acute fetal hypovolemia or hemorrhagic shock (placental abruption, vasa praevia rupture, twin-to-twin transfusion, umbilical cord avulsion) manifested by persistent pallor, poor capillary refill (> 3 seconds), weak pulses, and failure of heart rate to respond to PPV and compressions.
   • Fluids: Isotonic 0.9% Normal Saline or un-crossmatched Type O Rh-negative Packed Red Blood Cells (PRBCs).
   • Dose: 10 mL/kg IV/IO infused over 5 to 10 minutes.
   • Caution: Do NOT administer rapid unindicated volume expanders in normovolemic asphyxiated neonates; sudden hypervolemia provokes intraventricular hemorrhage and worsens myocardial failure.

The APGAR Scoring System: Structure, Clinical Utility & Limitations

Developed by Dr. Virginia Apgar in 1952, the APGAR score provides a standardized, reproducible assessment of the newborn's transitional clinical status across five objective physiological parameters:

Timing & Interpretation

• Standard Timestamps: Recorded routinely at 1 minute and 5 minutes after birth.
• Extended Scoring: If the5-minute score is<7, repeat assessment every5 minutes for up to20 minutes, recording concurrent resuscitative interventions. There is no requirement for two consecutive scores>=7.
• Score Stratification:
  • 7 to 10: Reassuring; normal transitional status.
  • 4 to6: Moderately abnormal in term/late-preterm infants; assess breathing, heart rate and the clinical context to determine treatment.
  • 0 to3: Low score in term/late-preterm infants; individual clinical findings determine which resuscitation steps are needed.

CRITICAL CLINICAL RULE: APGAR Is Not a Resuscitation Trigger

In Caribbean registration examinations, a paramount pitfall tested repeatedly is the timing of resuscitation. The clinician must NEVER delay or wait for the 1-minute APGAR score to initiate neonatal resuscitation. Resuscitation decisions are driven second-by-second during the Golden Minute by evaluating respirations and heart rate. Waiting 60 seconds to tabulate an APGAR score before delivering positive pressure ventilation will cause irreversible hypoxic-ischemic neurological injury and cardiac arrest. Furthermore, a low 1-minute APGAR score alone does not predict long-term neurological outcome or cerebral palsy; however, a persistently low score at 15 to 20 minutes (particularly scores of 0 to 3) correlates strongly with hypoxic-ischemic encephalopathy (HIE) and long-term neurodevelopmental impairment.

Prematurity Complications: Pathophysiology & Evidence-Based Management

Preterm neonates (< 37 completed weeks of gestation, particularly very low birth weight [< 1500 g] and extremely preterm [< 28 weeks] infants) face high risks of multi-organ morbidity due to anatomical and functional organ immaturity.

1. Respiratory Distress Syndrome (RDS)

• Pathophysiology: Deficiency of pulmonary surfactant synthesized by type II pneumocytes, which normally matures after 34 to 35 weeks gestation under endogenous glucocorticoid surges. Surfactant (primarily dipalmitoylphosphatidylcholine) reduces alveolar surface tension; its absence produces end-expiratory diffuse microatelectasis, decreased pulmonary compliance, ventilation-perfusion mismatch, intrapulmonary right-to-left shunting, severe hypoxia, and progressive respiratory acidosis. Injured alveolar epithelium exudes plasma proteins and fibrin, forming eosinophilic hyaline membranes.
• Clinical Presentation: Appears immediately or within 4 to 6 hours of birth: tachypnea (> 60 breaths/min), expiratory grunting (partial closure of vocal cords to generate auto-PEEP and maintain functional residual capacity), intercostal and subcostal retractions, nasal flaring, and central cyanosis.
• Radiographic Features: Chest X-ray displays diffuse, uniform, symmetrical "ground-glass" reticulogranular opacities, reduced lung volumes (hypoexpansion), and prominent air bronchograms (air-filled bronchial tree silhouetted against collapsed, opaque alveoli).
• Management:
  • Antenatal Corticosteroids: Administer Betamethasone 12 mg IM every 24 hours x 2 doses (or Dexamethasone 6 mg IM every 12 hours x 4 doses) to all pregnant women between 24 and 34 weeks at risk of imminent preterm delivery. Corticosteroids cross the placenta, accelerating type II pneumocyte maturation and surfactant production, reducing RDS, intraventricular hemorrhage and neonatal mortality.
  • Early Nasal CPAP: Initiate early continuous positive airway pressure (5 to 6 cmH2O) immediately in the delivery room via nasal prongs to maintain end-expiratory alveolar stability, avoiding invasive mechanical ventilation where possible.
  • Exogenous Surfactant Therapy: Administered via endotracheal instillation (Poractant alfa 200 mg/kg or Beractant 100 mg/kg) in infants requiring FiO2 > 30% on CPAP. Techniques include InSurE (Intubate-Surfactant-Extubate to CPAP) or LISA / MIST (Less Invasive Surfactant Administration / Minimally Invasive Surfactant Therapy via a thin vascular catheter placed through the vocal cords during spontaneous breathing).

2. Necrotizing Enterocolitis (NEC)

• Pathophysiology: A devastating inflammatory necrosis of the bowel wall (predominantly terminal ileum and ascending colon) occurring in 5% to 10% of VLBW infants. Etiology involves a multifactorial triad: intestinal mucosal immaturity (compromised tight junctions and mucus production), abnormal bacterial colonization (dysbiosis triggered by early broad-spectrum antibiotics or formula feeding), and ischemia-reperfusion mucosal injury. Enteral feeding with bovine-based infant formula exposes the immature mucosa to pro-inflammatory cascades, bacterial translocation, intramural gas production, full-thickness gangrene, and bowel perforation. Mother's own breast milk provides potent protective immunoglobulins (IgA), lactoferrin, and oligosaccharides, reducing NEC risk compared with formula feeding.
• Clinical Features: Typically develops during the 2nd to 3rd week of life after enteral feedings have commenced: feeding intolerance, high gastric residuals (especially bilious or coffee-ground aspirates), abdominal distension, absent bowel sounds, hematochezia (frank or occult rectal bleeding), abdominal wall erythema/edema, lethargy, temperature instability, apnea, and septic shock.
• Modified Bell Staging & Radiographic Hallmarks:
  • Stage I (Suspected): Lethargy, abdominal distension, occult bloody stools; plain abdominal radiograph shows non-specific ileus or bowel dilation.
  • Stage II (Definite): Marked distension, absent bowel sounds, persistent metabolic acidosis, thrombocytopenia; pathognomonic radiograph shows pneumatosis intestinalis (linear or bubbly gas pockets dissecting within the submucosal/subserosal bowel wall) and/or portal venous gas (branching lucencies extending toward the liver periphery).
  • Stage III (Advanced): Severe systemic illness with shock, acidosis or peritonitis. IIIA has no demonstrated perforation; IIIB has perforation with pneumoperitoneum. Free gas may appear beneath the diaphragm, as a supine football sign, or anterior to the liver on cross-table lateral/left-decubitus films.
• Management:
  • Start bowel rest (NPO), gastric decompression, IV fluids and broad-spectrum antibiotics, with parenteral nutrition for prolonged bowel rest. Ampicillin plus gentamicin, with metronidazole for definite/severe NEC, is a recognised regimen. For suspected stageI, reassess at48–72 hours and stop antibiotics if NEC/sepsis is excluded. Definite stageII/III usually requires7–14 days according to severity, cultures and response.
  • Serial abdominal radiographs every 6 to 8 hours.
  • Obtain early paediatric surgical consultation. Pneumoperitoneum indicating perforation requires operative intervention, using laparotomy or selected peritoneal drainage in unstable infants. A persistent fixed loop, abdominal-wall changes, portal gas or deterioration despite medical therapy requires urgent surgical reassessment; these findings are not individually automatic indications for resection.

3. Intraventricular Hemorrhage (IVH)

• Pathophysiology: Hemorrhage originating in the subependymal germinal matrix—a highly vascular, gelatinous, metabolically active embryonic zone located beneath the ependyma of the lateral ventricles that gives rise to neuronal and glial precursors. The germinal matrix is richly supplied by fragile, thin-walled, immature capillary networks devoid of basement membrane support or smooth muscle. Autoregulation of cerebral blood flow is absent or severely impaired in preterm infants; sudden fluctuations in arterial blood pressure (provoked by rapid volume pushes, endotracheal suctioning, pneumothorax, hypoxia, hypercapnia, or acidosis) lead to rupture of these microvessels. Vulnerability is highest in infants born at < 32 weeks gestation or < 1500 g birth weight, with > 90% of bleeds occurring within the first 72 hours of life.
• Papile Ultrasound Grading:
  • Grade I: Bleeding confined strictly to the subependymal germinal matrix.
  • Grade II: Intraventricular hemorrhage filling 10% to 50% of the lateral ventricle without ventricular dilatation.
  • Grade III: Intraventricular hemorrhage filling > 50% of the lateral ventricle with acute ventricular dilation (ventriculomegaly).
  • Grade IV: Intraventricular hemorrhage with extension into the adjacent brain parenchyma (periventricular hemorrhagic infarction caused by venous outflow occlusion of medullary veins).
• Surveillance & Complications: Routine screening cranial ultrasonography via the anterior fontanelle is performed between day 7 and 14 of life (and repeated at 36 to 40 weeks postmenstrual age) for all infants <= 30 weeks or <= 1500 g. Long-term sequelae of high-grade IVH (Grades III and IV) include post-hemorrhagic hydrocephalus (mandating ventricular reservoir placement, subgaleal shunt, or ventriculoperitoneal shunt) and spastic diplegic or quadriplegic cerebral palsy accompanied by neurodevelopmental delay.

4. Patent Ductus Arteriosus (PDA)

• Pathophysiology: In healthy term infants, elevation of arterial PaO2 and falling circulating prostaglandin E2 (PGE2) trigger functional ductal constriction during the first24–48 hours in healthy term infants; anatomical obliteration follows over the next2–3 weeks. In preterm infants, the ductal smooth muscle is relatively insensitive to oxygen and exhibits hypersensitivity to circulating PGE2 and nitric oxide. Persistent patency results in a significant left-to-right shunt from the high-pressure aorta into the low-pressure pulmonary artery, causing pulmonary hyperperfusion, pulmonary edema, worsening respiratory failure, and systemic "diastolic steal" that compromises perfusion to the kidneys, intestines (increasing NEC risk), and brain.
• Clinical Signs: Typically manifests on days 3 to 7 as respiratory status deteriorates: hyperdynamic precordium, bounding peripheral pulses (high systolic, low diastolic, wide pulse pressure), and a continuous rough "machinery" murmur or systolic murmur best heard at the upper left sternal border / left infraclavicular region.
• Management: Confirm PDA and haemodynamic significance by echocardiography. Stable preterm infants commonly receive supportive/expectant care; routine closure in the first2 weeks has not improved outcomes. Individualise fluids and respiratory support rather than prescribing universal restriction. Selected persistent symptomatic PDAs may receive ibuprofen, indomethacin or paracetamol after neonatal assessment. Ligation or transcatheter closure is considered for significant persistent symptoms when medication fails or is unsuitable.

5. Retinopathy of Prematurity (ROP)

• Pathophysiology: A two-phase vasoproliferative disorder of the developing retinal vasculature. Phase 1 occurs following preterm delivery when excessive oxygen exposure (hyperoxia) suppresses vascular endothelial growth factor (VEGF), causing cessation of normal retinal vessel growth (vaso-obliteration). Phase 2 occurs as the peripheral avascular retina becomes increasingly metabolically active and ischemic, triggering massive compensatory overexpression of VEGF, driving disorganized, pathological neovascularization (vasoproliferation). These abnormal fibrovascular fronds contract, exerting traction that causes retinal detachment and permanent blindness.
• Screening: All infants born at <= 30 weeks gestation or with a birth weight <= 1500 g (or selected unstable infants up to 32 weeks / 2000 g) must undergo indirect ophthalmoscopic retinal screening by an experienced ophthalmologist using a scheduled first examination. Under the AAP schedule, this is generally 31 weeks postmenstrual age or4 weeks postnatal age, whichever is later; the ophthalmologist may arrange earlier assessment for the most immature/high-risk infants and sets subsequent intervals.
• Management: Careful oxygen titration (maintaining SpO2 between 91% and 95%, avoiding hyperoxic spikes). Treat type1 ROP promptly: zoneI disease with plus disease, zoneI stage3 without plus, or zoneII stage2/3 with plus. Treatment is generally required within72 hours, using laser ablation or selected intravitreal anti-VEGF therapy. Continued specialist follow-up is essential, particularly after anti-VEGF because late reactivation can occur.